Incomplete Deprotection in Peptides: A Guide to Mass Increments

Some impurities in a synthetic peptide are close relatives of the target with a small chemical piece still attached. Incomplete deprotection in peptides leaves the sequence correct but the mass too high, by an amount that matches one specific protecting group. Once you know the handful of increments that matter, an unexplained peak in a mass spectrum often identifies itself in a few seconds of arithmetic. This guide lists those increments, explains why certain residues cause most of the trouble, and shows how to tell leftover protection apart from a look-alike side reaction when reviewing lots.

How permanent protection comes off

During solid-phase assembly, each reactive side chain wears a protecting group so that coupling reagents only ever meet the free N-terminal amine. In the dominant Fmoc/tBu approach, those side-chain groups are acid-labile and stay on until the very end.

The final step is a cleavage “cocktail” built on trifluoroacetic acid (TFA). It does two things in one operation: it frees the peptide from the resin, and it strips every acid-labile side-chain group. Both reactions need to run to completion on every molecule. Where one group on one side chain survives, that molecule is a protected variant: right sequence, right length, heavier by exactly the mass of what stayed on. The assembly steps themselves are described in the solid-phase synthesis cycle.

Reference table of mass increments

These are the monoisotopic mass additions to expect when a group is retained. Each one replaces a hydrogen, and the figures already account for that.

If the Acm group was meant to stay on, for example to direct a specific disulfide pairing, a +71 species is intended chemistry, not an impurity. Context matters.

Diagnosing incomplete deprotection from an unknown peak

1. Subtract the calculated monoisotopic mass of the target from the observed mass of the unknown.
2. Compare the difference with the table. A match to one increment points to a single retained group.
3. Check for multiples and combinations. +112 could be two tBu groups; +504 could be two Pbf groups; +308 could be Pbf plus tBu.
4. Confirm that the sequence actually contains a residue that carries that group. A +252 species in a peptide with no arginine needs a different explanation.
5. Where two candidate explanations sit within a dalton or so of each other, rely on accurate mass or tandem MS rather than nominal values.

Charge state matters too. On a doubly charged ion a +252 Da difference appears as +126 on the m/z axis, so always work with deconvoluted neutral masses.

Arginine and the Pbf problem

The arginine side chain is strongly basic, and the sulfonyl-based groups used to mask it are correspondingly resistant to acid. Pbf was introduced as a more labile replacement for older arginine protecting groups, yet it remains the slowest of the common set to come off. Sequences with several arginines therefore need longer exposure to the cleavage cocktail.

That creates a genuine trade-off. Extending the cleavage to chase the last Pbf group gives other side reactions more time, and tryptophan and methionine elsewhere in the chain are the usual casualties. A synthesis chemist may accept a small residual +252 peak rather than risk a larger family of oxidised or alkylated species. On a report, a minor, well-separated protected-arginine peak is often the visible result of that compromise.

Same mass, different cause: re-attachment

Removed protecting groups leave as reactive carbocations. The tert-butyl and trityl cations in particular will alkylate electron-rich side chains if nothing intercepts them. Tryptophan, methionine, cysteine and tyrosine are the usual targets. Sulfonyl fragments from arginine protection can also modify tryptophan, which is one reason Trp is often supplied with its own Boc group.

Scavengers in the cocktail, such as water, triisopropylsilane, thioanisole and ethanedithiol, exist to capture those cations first. When scavenging falls short, the product can show a +56 or +242 species even though deprotection itself went fully to completion. The mass is identical to a retained group, but the chemistry is the reverse: the group came off and then landed somewhere else. Tandem MS that locates the modification on a residue which never carried that group settles the question.

Where these species show up, and how to track them across lots

Protecting groups are bulky and hydrophobic, so a protected variant usually elutes after the main peak in reversed-phase HPLC, often with clear separation. That makes these impurities easier to resolve and quantify than deamidation or isomerisation products, which sit almost on top of the parent.

For a lab that receives several lots of one peptide, a short routine helps:

• Record each late-eluting impurity by relative retention and by its mass difference from the target.
• Label it by class, such as “+252, probable Arg(Pbf)”, rather than as an unnamed peak.
• Compare the class profile from lot to lot. A new class appearing is more informative than a small shift in total purity.

A certificate that names impurities by mass difference gives you that class information directly. Where only area percentages appear, a well-resolved peak eluting after the target points towards retained protection rather than an isomer. For the broader impurity families, see deletion, truncation and oxidation impurities, and for how the two main synthesis chemistries compare, Fmoc vs Boc peptide synthesis.

Bulk Peptides provides these materials purely for laboratory research and analytical work. They are not for human or animal use.